Skip to main content
Mostly Clear icon
88º

Go to the KPRC homepage

Join Insider
    • News
    • Watch Live
    • Immigration
    • Business
    • Click2Vote
    • Consumer
    • Crime
    • Education
    • Entertainment
    • Health
    • History
    • Local News
    • Money
    • National
    • Pets
    • Politics
    • Tech
    • Texas
    • World
    • Weather
    • Traffic
    • Alerts
    • Click2Pins
    • Flood Tracker
    • Galveston
    • Houston Zoo
    • Hurricane Headquarters
    • Live Cams
    • KPRC 2+
    • Watch Live
    • The Evidence Room
    • Solutionaries
    • NEXTGEN TV
    • Investigates
    • The Bench
    • The Evidence Room
    • Astroworld Festival Tragedy
    • DRAINED
    • 2 Helps You
    • Contact 2 Helps You
    • Sports
    • Texans
    • Texans Stats
    • Astros
    • Astros Stats
    • Rockets
    • Rockets Stats
    • Friday Football Frenzy
    • Athlete of the Week
    • Aggies
    • Cougars
    • Dynamo
    • Longhorns
    • NCAA
    • Olympics
    • Discover
    • Contact Us
    • Things To Do
    • Events Calendar
    • Contests & Rules
    • Click2Pins
    • Click2Save Deals
    • DIY
    • Events
    • Families
    • Food and Drinks
    • Go Gold
    • Habitat For Humanity
    • KPRC 2 Community
    • Outdoors
    • Podcasts
    • Senior Scholarships
    • Travel
    • TV Listings
    • News Team
    • Houston Life
    • About Us
    • Be on the Show
    • Seen on Houston Life
    • Eat Like a Local
    • Newsletters
  • News
  • Weather
  • KPRC 2+
  • Investigates
  • 2 Helps You
  • Sports
  • Discover
  • Houston Life
  • Newsletters
Click2Houston.com
  • News
  • Weather
  • KPRC 2+
  • Investigates
  • 2 Helps You
  • Sports
  • Discover
  • Houston Life
  • Newsletters
  • LIVE

WEATHER ALERT

3 warnings and 3 advisories in effect for 6 regions in the area

BRAD WENSTRUP


No description available

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Read full article: Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.

No description available

Congress targets Chinese influence in health tech. It could come with tradeoffs

Read full article: Congress targets Chinese influence in health tech. It could come with tradeoffs

A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China.

No description available

AP Decision Notes: What to expect in Ohio's presidential and state primaries

Read full article: AP Decision Notes: What to expect in Ohio's presidential and state primaries

The most high-profile election in Ohio’s primary on Tuesday will be the Republican contest to take on the state’s Democratic U.S. senator.

No description available

New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay

Read full article: New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay

Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.

No description available

Anthony Fauci will testify before Congress on COVID origins and the US pandemic response

Read full article: Anthony Fauci will testify before Congress on COVID origins and the US pandemic response

Former chief White House medical adviser Anthony Fauci is expected to testify before Congress early next year as part of Republicans’ yearslong investigation into the origins of COVID-19 and the U.S. response to the disease.

No description available

The GOP congressman who leads the House's probe of COVID-19's origins says he won't seek reelection

Read full article: The GOP congressman who leads the House's probe of COVID-19's origins says he won't seek reelection

The Republican congressman who leads the House GOP's investigation of the origins of COVID-19 says he won't seek reelection next year.

No description available

Correction: Congress-Oversight-COVID story

Read full article: Correction: Congress-Oversight-COVID story

In a story published February 13, 2023, about a congressional investigation into COVID-19 origins, The Associated Press erroneously reported that Rep. James Comer is from Tennessee.

No description available

American spy agencies review their misses on Ukraine, Russia

Read full article: American spy agencies review their misses on Ukraine, Russia

U.S. intelligence agencies have begun a review of how they judge the will and ability of foreign governments to fight.

No description available

GOP seeks to convince vaccine skeptics within its own ranks

Read full article: GOP seeks to convince vaccine skeptics within its own ranks

With vaccination rates lagging in red states, Republican leaders have begun stepping up efforts to persuade their supporters to get the shot, at times combating misinformation spread by some of their own.

No description available

Trump, Lee, Tillis: Congress reconsiders testing its own

Read full article: Trump, Lee, Tillis: Congress reconsiders testing its own

Mike Lee, R-Utah, and Thom Tillis, R-N.C., became the latest members of Congress to test positive for the virus that has killed more than 205,000 Americans. All three attended the White House Rose Garden introduction Saturday of Trump's nominee for the Supreme Court, Amy Coney Barrett. Nationally and on Capitol Hill, there are no comprehensive plans requiring testing or wearing masks. House members can vote by proxy through their colleagues, to cut down on the number of people milling around. Lee, Tillis and other Republican members of the panel were among those who attended the Rose Garden event on Saturday.

BACK TO TOP
  • TV Listings

  • Email Newsletters

  • RSS Feeds

  • Contests and Rules

  • Contact Us

  • Meet the Team

  • Careers at KPRC

  • Closed Captioning / Audio Description

  • Public File

  • Current EEO Report

  • Terms of Use

  • Privacy Policy

  • Do Not Sell My Info

  • FCC Applications

Follow Us
Visit our YouTube page (opens in a new tab)
Visit our Facebook page (opens in a new tab)
Visit our Instagram page (opens in a new tab)
Visit our X page (opens in a new tab)
Visit our RSS Feed page (opens in a new tab)
Get Results With OmneOmne Results Logo

If you need help with the Public File, call (713) 778-4745

At KPRC, we are committed to informing and delighting our audience. In our commitment to covering our communities with innovation and excellence, we incorporate Artificial Intelligence (AI) technologies to enhance our news gathering, reporting, and presentation processes. Read our article to see how we are using Artificial Intelligence.


Graham Media Group LogoGraham Digital Logo

Copyright © 2025 Click2Houston.com is managed by Graham Digital and published by Graham Media Group, a division of Graham Holdings.